99 related articles for article (PubMed ID: 9562450)
1. Prognostic factors in metastatic germ cell tumors.
Schmoll HJ; Beyer J
Semin Oncol; 1998 Apr; 25(2):174-85. PubMed ID: 9562450
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.
Fosså SD; Stenning SP; Gerl A; Horwich A; Clark PI; Wilkinson PM; Jones WG; Williams MV; Oliver RT; Newlands ES; Mead GM; Cullen MH; Kaye SB; Rustin GJ; Cook PA
Br J Cancer; 1999 Jul; 80(9):1392-9. PubMed ID: 10424741
[TBL] [Abstract][Full Text] [Related]
3. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
[TBL] [Abstract][Full Text] [Related]
4. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.
Sonneveld DJ; Hoekstra HJ; van der Graaf WT; Sluiter WJ; Mulder NH; Willemse PH; Koops HS; Sleijfer DT
Cancer; 2001 Apr; 91(7):1304-15. PubMed ID: 11283931
[TBL] [Abstract][Full Text] [Related]
5. Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning.
van Dijk MR; Steyerberg EW; Stenning SP; Dusseldorp E; Habbema JD
Br J Cancer; 2004 Mar; 90(6):1176-83. PubMed ID: 15026798
[TBL] [Abstract][Full Text] [Related]
6. Germ cell tumours of the testis: clinical features, treatment outcome and prognostic factors.
Bhutani M; Kumar L; Seth A; Thulkar S; Vijayaraghavan M; Kochupillai V
Natl Med J India; 2002; 15(1):18-21. PubMed ID: 11855586
[TBL] [Abstract][Full Text] [Related]
7. Mediastinal metastases from testicular nonseminomatous germ cell tumors: patterns of dissemination and predictors of long-term survival with surgery.
Kesler KA; Brooks JA; Rieger KM; Fineberg NS; Einhorn LH; Brown JW
J Thorac Cardiovasc Surg; 2003 Apr; 125(4):913-23. PubMed ID: 12698156
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
9. Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors.
Fizazi K; Culine S; Kramar A; Amato RJ; Bouzy J; Chen I; Droz JP; Logothetis CJ
J Clin Oncol; 2004 Oct; 22(19):3868-76. PubMed ID: 15302906
[TBL] [Abstract][Full Text] [Related]
10. Advanced seminoma--treatment results and prognostic factors for survival after first-line, cisplatin-based chemotherapy and for patients with recurrent disease: a single-institution experience in 145 patients.
Gholam D; Fizazi K; Terrier-Lacombe MJ; Jan P; Culine S; Theodore C
Cancer; 2003 Aug; 98(4):745-52. PubMed ID: 12910518
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of germ cell tumors at the threshold of the third millennium].
Géczi L; Biron P; Droz JP
Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261
[TBL] [Abstract][Full Text] [Related]
12. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
13. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of advanced testicular cancer and toxicity of chemotherapy].
Kawakita M; Matsuda T; Terachi T; Yoshida O
Hinyokika Kiyo; 1999 Nov; 45(11):783-6. PubMed ID: 10637744
[TBL] [Abstract][Full Text] [Related]
15. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables.
Vaena DA; Abonour R; Einhorn LH
J Clin Oncol; 2003 Nov; 21(22):4100-4. PubMed ID: 14615439
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of primary mediastinal germ cell tumors].
Yoshitake T; Itoyama S
Rinsho Kyobu Geka; 1989 Feb; 9(1):29-34. PubMed ID: 9301895
[TBL] [Abstract][Full Text] [Related]
18. Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan.
Shintaku I; Satoh M; Okajima E; Fujimoto H; Kamoto T; Ogawa O; Kawai K; Akaza H; Tsukamoto T; Naito S; Miki T; Arai Y
Jpn J Clin Oncol; 2008 Apr; 38(4):281-7. PubMed ID: 18321891
[TBL] [Abstract][Full Text] [Related]
19. Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers.
Albers P; Ganz A; Hannig E; Miersch WD; Müller SC
J Urol; 2000 Aug; 164(2):381-4. PubMed ID: 10893590
[TBL] [Abstract][Full Text] [Related]
20. Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
Mazumdar M; Bacik J; Tickoo SK; Dobrzynski D; Donadio A; Bajorin D; Motzer R; Reuter V; Bosl GJ
J Clin Oncol; 2003 Jul; 21(14):2679-88. PubMed ID: 12860944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
